SCHEMBL16273307

SCHEMBL16273307

O=C(/C=C/c1ccc(O)c(O)c1)NNC(=O)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 10/20 0.63
MMP2 P08253 10/20 0.63
MMP9 P14780 10/20 0.63
KDM4E B2RXH2 3/20 0.59
POLB P06746 3/20 0.59
MEN1 O00255 2/20 0.59
GAA P10253 2/20 0.59
MAPT P10636 2/20 0.59
HPGD P15428 2/20 0.59
KMT2A Q03164 2/20 0.59
NPC1 O15118 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
PTPN1 P18031 2/20 0.57
ARG1 P05089 1/20 0.56
HSD17B10 Q99714 2/20 0.55
ALDH1A1 P00352 2/20 0.55
CYP2C9 P11712 2/20 0.55
APP P05067 2/20 0.55
HDAC3 O15379 1/20 0.55
CA12 O43570 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28052720 1.00 MMP1 (0.63) MMP1MMP2MMP9KDM4EPOLB
SCHEMBL28052575 0.90 MMP1 (0.65) MMP1MMP2MMP9KDM4EPOLB
SCHEMBL16274512 0.86 L3MBTL1 (0.61) MMP1MMP2MMP9KDM4EPOLB
SCHEMBL28052692 0.85 ALDH1A1 (0.63) MMP1MMP2MMP9KDM4EPOLB
SCHEMBL28052691 0.85 ALDH1A1 (0.63) MMP1MMP2MMP9KDM4EPOLB
SCHEMBL28052580 0.83 MMP1 (0.67) MMP1MMP2MMP9POLBPTPN1
SCHEMBL11704382 0.79 ALDH1A1 (0.63) MMP1MMP2MMP9KDM4EPOLB
SCHEMBL11704385 0.79 ALDH1A1 (0.63) MMP1MMP2MMP9KDM4EPOLB
SCHEMBL25214104 0.79 MAPT (0.75) MMP1MMP2MMP9KDM4EPOLB
SCHEMBL30384507 0.79 MAPT (0.75) MMP1MMP2MMP9KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105461591-A Cinnamoyl hydrazide compound and preparation and application thereof UNIV LANZHOU 2016-04-06 CN disclosed
US-9255071-B2 Compounds having antibacterial activity, process for their preparation and pharmaceutical compositions comprising them CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TÉCNICAS (CONICET) (AR) 2016-02-09 US disclosed
US-20140357678-A1 COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (CONICET) (AR) 2014-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140357678-A1 COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM C5, CBR3, C1R MMP1 3041/4885MMP2 1470/4885MMP9 2521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.